Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Associate Professor
Department of Clinical Hematology
Université Paris Saclay
Paris, France
Physician
Department of Hematology
Gustave Roussy
Villejuif, France
Stéphane de Botton, MD: consultant/advisor/speaker: AbbVie, Astellas Pharma, Bristol-Myers Squibb, GlaxoSmithKline, Jazz Pharmaceuticals, SERVIER, Syndax; research funding: Auron Therapeutics; Forma Therapeutics; travel/accommodations/expenses: AbbVie; Bristol-Myers Squibb; SERVIER.
Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain
Jesús F. San-Miguel, MD, PhD: consultant: AbbVie, Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Karyopharm, MSD, Novartis, Regeneron, Roche, Sanofi, SecuraBio, Takeda.
Director of Indolent Lymphoproliferative Disorders
Department of Hematology
Niguarda Cancer Center
Niguarda Hospital
Milan, Italy
Alessandra Tedeschi, MD: consultant: AbbVie, AstraZeneca, BeiGene, Janssen.
Important results from many clinical trials in hematologic malignancies were discussed at the 2022 European Hematology Association (EHA) annual meeting. Below, experts have highlighted a few key abstracts, which we will cover online as part of CCO’s Independent Conference Coverage of EHA 2022. Remember to check the CCO website often for a downloadable slideset summarizing the data from these studies and then again for a CME-certified online activity featuring expert analyses and perspectives on the clinical implications of the new data.
Top Picks: Lymphomas
Alessandra Tedeschi, MD, identified the following important and potentially practice-changing studies in lymphomas reported at EHA 2022.
Top Picks: Leukemias
Stéphane de Botton, MD, identified 3 key studies in acute myeloma leukemia (AML) reported at EHA 2022.
Top Picks: Multiple Myeloma
Jesús F. San-Miguel, MD, PhD, identified the following key studies in multiple myeloma (MM) reported at EHA 2022.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.